TPMT, UGT1A1 and DPYD: genotyping to ensure safer cancer therapy?

This publication has 62 references indexed in Scilit:

• The Uracil Breath Test in the Assessment of Dihydropyrimidine Dehydrogenase Activity: Pharmacokinetic Relationship between Expired 13CO2 and Plasma [2-13C]Dihydrouracil
  Clinical Cancer Research, 2006
• Haplotype structures of the UGT1A gene complex in a Japanese population
  The Pharmacogenomics Journal, 2005
• Perspectives on Human Genetic Variation from the HapMap Project
  PLoS Genetics, 2005
• A haplotype map of the human genome
  Nature, 2005
• Reply to 'Haplotype block structure of the cytochrome P450 CYP2C gene cluster on chromosome 10'
  Nature Genetics, 2005
• A single-nucleotide polymorphism tagging set for human drug metabolism and transport
  Nature Genetics, 2004
• Heritability and Linkage Analysis of Sensitivity to Cisplatin-Induced Cytotoxicity
  Cancer Research, 2004
• Comprehensive UGT1A1 Genotyping in a Japanese Population by Pyrosequencing
  Clinical Chemistry, 2003
• Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia
  The Journal of Pediatrics, 1991
• Familial Pyrimidinemia and Pyrimidinuria Associated with Severe Fluorouracil Toxicity
  New England Journal of Medicine, 1985